Search any Pharmacy Practice News related CME activities from CMEZone.

Advancing Care in Non–Muscle-Invasive Bladder Cancer

The management of non–muscle-invasive bladder cancer (NMIBC) can represent a significant clinical challenge. High-risk patients and those unresponsive to first-line standard-of-care (SOC) treatment face a substantial risk for disease progression, recurrence, and bladder loss, which can adversely affect their quality of life (QoL) and ...

Fibrinogen Replacement Therapy: From Deficiency Recognition to Treatment Strategies

Fibrinogen deficiency presents significant risks for both bleeding (hemorrhagic) and clotting (thrombotic) complications, making it one of the most critical coagulation disorders. This deficiency can be congenital, which is inherited, or acquired, and is associated with clinical bleeding ranging from mild to severe, depending on the ...

Microbiome-Based Therapies in the Treatment of Clostridioides Difficile Infection

The goal of this program is to educate clinicians about new data supporting the use of microbiota-based therapies in the prevention of recurrent Clostridioides difficile infection (rCDI) and how these agents can be integrated into clinical patient care.